Purple Biotech ADR PPBT

Healthcare

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

NDAQ:PPBT - Post by User

Purple Biotech ADR

Bullboard Posts

Post by coolfooldumbguyon Jan 15, 2019 2:02pm

195 Views

Post# 29234997

it's a sell today for me

during the lunch hour,was able to sell it at $2.55 per share for a tidy profit of 137% gain on my money,so it was a great trade for me and for the start of this year glta shareholders.

Bullboard Posts

One of the best stocks for a silver rebound play